AP Biosciences (ROCO:6945) Pre-Tax Income : NT$-422.75 Mil (TTM As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is AP Biosciences Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. AP Biosciences's pretax income for the six months ended in Dec. 2024 was NT$-196.48 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-422.75 Mil. AP Biosciences's pretax margin was %.

During the past 5 years, AP Biosciences's highest Pretax Margin was 30.43%. The lowest was -2682.77%. And the median was -1051.98%.

AP Biosciences Pre-Tax Income Historical Data

The historical data trend for AP Biosciences's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AP Biosciences Pre-Tax Income Chart

AP Biosciences Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Pre-Tax Income

0.04

-187.61

-288.54

-339.30

-422.75

AP Biosciences Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Pre-Tax Income	Get a 7-Day Free Trial			-126.13	-118.08	-221.21	-226.27	-196.48

Competitive Comparison of AP Biosciences's Pre-Tax Income

For the Biotechnology subindustry, AP Biosciences's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AP Biosciences's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AP Biosciences's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where AP Biosciences's Pre-Tax Income falls into.

Save Embed

;

Save Embed

;

AP Biosciences Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

AP Biosciences's Pretax Income for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-439.056	+	0	+	-1.648	+	13.52	+	4.438
	=	-422.75

AP Biosciences's Pretax Income for the quarter that ended in Dec. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-205.677	+	0	+	-0.797	+	10.246	+	-0.24700000000001
	=	-196.48

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-422.75 Mil.

AP Biosciences (ROCO:6945) Pre-Tax Income Explanation

AP Biosciences's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-196.475	/	0
	=	%

During the past 5 years, AP Biosciences's highest Pretax Margin was 30.43%. The lowest was -2682.77%. And the median was -1051.98%.

AP Biosciences Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of AP Biosciences's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

AP Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3, Park Street, 17th Floor, Taipei, TWN

Website

https://www.apbioinc.com

AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.

AP Biosciences Headlines

No Headlines